Factory 99% Ozagrel Sodium CAS 189224-26-8 Chemical Intermediate Ozagrel Sodium

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A367
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Ozagrel Sodium
• CAS: 189224-26-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Neuroprotection
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Ozagrel Sodium
Appearance	White Powder
CAS NO.	189224-26-8
Molecular Formula	C13H11N2NaO2
Storage	Keep in a cool, dry, dark location

 

Ozagrel Sodium is a medicinal compound belonging to the class of thromboxane A2 synthase inhibitors. It is primarily used in the treatment of cerebrovascular disorders by inhibiting platelet aggregation and reducing vascular spasms.

 

 

1. Cerebrovascular Diseases: Administered to patients with acute ischemic stroke, including cerebral infarction, to improve cerebral blood flow and reduce the risk of further neurological damage.
2. Prevention of Thrombosis: Used to prevent the formation of blood clots in patients with high risk of thrombosis, such as those with cardiovascular disease or undergoing surgical procedures.
3. Adjuvant Therapy: May be used as an adjuvant therapy in combination with other medications to enhance the treatment outcome in cerebrovascular and cardiovascular conditions.

1. Inhibition of Platelet Aggregation: By inhibiting the synthesis of thromboxane A2, Ozagrel Sodium blocks the platelet aggregation pathway, thereby reducing the risk of thrombus formation.
2. Vasodilation: It has vasodilatory effects, which help to reduce vascular spasms and improve blood flow to the affected areas.
3. Neuroprotection: By improving cerebral blood flow and energy metabolism, Ozagrel Sodium may exert neuroprotective effects, aiding in the recovery of neurological function in patients with cerebrovascular disorders.